Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vicky Nahra"'
Autor:
Hazem I. Assi, Nour Abdul Halim, Ibrahim Alameh, Jessica Khoury, Vicky Nahra, Fares Sukhon, Maya Charafeddine, Clara El Nakib, Nour Moukalled, Maroun Bou Zerdan, Pierre Bou Khalil
Publikováno v:
Critical Care Research and Practice, Vol 2021 (2021)
Introduction. Decisions regarding whether advanced cancer patients should be admitted to the ICU are based on a complex suite of considerations, including short- and long-term prognosis, quality of life, and therapeutic options to treat cancer. We ai
Externí odkaz:
https://doaj.org/article/929e36ff5c7e4290bd051c509871785d
Publikováno v:
Mediterranean Journal of Rheumatology
Mediterranean Journal of Rheumatology, Vol 31, Iss 4, Pp 400-405 (2020)
Mediterranean Journal of Rheumatology, Vol 31, Iss 4, Pp 400-405 (2020)
Objectives Infliximab (Remicade®) was the first tumour necrosis factor-α (TNF) inhibitor to receive its initial marketing approval from the US Food and Drug Administration (FDA) for the treatment of Crohn's disease. Following that, infliximab becam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5f3718cb880fa18e037bbf08f7efc10
http://europepmc.org/articles/PMC7841097
http://europepmc.org/articles/PMC7841097
Autor:
Clara El Nakib, Vicky Nahra, Hazem I. Assi, Maroun Bou Zerdan, Nour Abdul Halim, Maya Charafeddine, Nour Moukalled, Jessica Khoury, Ibrahim A. Alameh, Fares Sukhon, Pierre Bou Khalil
Publikováno v:
Critical Care Research and Practice
Critical Care Research and Practice, Vol 2021 (2021)
Critical Care Research and Practice, Vol 2021 (2021)
Introduction. Decisions regarding whether advanced cancer patients should be admitted to the ICU are based on a complex suite of considerations, including short- and long-term prognosis, quality of life, and therapeutic options to treat cancer. We ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1287f554b36cc642b4333ec10401bf07
https://pubmed.ncbi.nlm.nih.gov/34513091
https://pubmed.ncbi.nlm.nih.gov/34513091
Autor:
Houda, Ziadeh, Monique, Chaaya, Samar, Rachidi, Khalil El, Asmar, Amal, Al-Hajje, Lamiaa, Hamieh, Vicky, Nahra, Imad, Uthman
Publikováno v:
Mediterranean Journal of Rheumatology. 33:218
The aim of the Lebanese hospital-based Rheumatoid Arthritis (RA) registry, initiated in 2011, is to evaluate the safety and efficacy of biologic agents among patients seeking care at the American University of Beirut Medical Center (AUBMC). We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487388bf7b2b844021d2949f78b21c2c
https://doi.org/10.31138/mjr.33.2.218
https://doi.org/10.31138/mjr.33.2.218